Jones Michael L
Exec. Director, Finance - PAO at BCRX
- Sold, on record
- $156k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Dec 15, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BCRXBIOCRYST PHARMACEUTICALS INCExec. Director, Finance - PAO
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BCRXPlan not statedMar 1, 2022 2022
Sold 2,300 shares at $17.20 ($40k)
Jones Michael L, Exec. Director, Finance - PAO
Sold 17% of holdings ($232k position)11,198 shares leftFirst sale on recordFiling
- 2 Form 4 sale BCRXUnusualDec 1, 2022 +275 days
Sold 8,600 shares at $13.01 ($112k)
Jones Michael L, Exec. Director, Finance - PAO
Sold 43.4% of holdings ($258k position)11,198 shares leftFiling
- 3 Form 4 sale BCRXPlan not statedDec 15, 2022 +14 days
Sold 445 shares at $10.90 ($5k)
Jones Michael L, Exec. Director, Finance - PAO
Sold 4% of holdings ($122k position)10,753 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | Dec 19, 2022 | BCRX | Exec. Director, Finance - PAO | Form 4 sale | 445 | $5k | 4.0% | Plan not stated | SEC |
| Dec 1, 2022 | Dec 2, 2022 | BCRX | Exec. Director, Finance - PAO | Form 4 sale | 8,600 | $112k | 43.4% | Unusual | SEC |
| Mar 1, 2022 | Mar 3, 2022 | BCRX | Exec. Director, Finance - PAO | Form 4 sale | 2,300 | $40k | 17.0% | Plan not stated | SEC |